Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion type Assertion NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_head.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion description "[Furthermore, GPR40 has drawn considerable interest as a novel therapeutic target to enhance insulin secretion in type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_provenance.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion evidence source_evidence_literature NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_provenance.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion SIO_000772 23631851 NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_provenance.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion wasDerivedFrom befree-20150227 NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_provenance.
- NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_assertion wasGeneratedBy ECO_0000203 NP432920.RAY54M8j_PkP7fPTY_BAwWlW5rYFkDZt_hd9klXYz0ips130_provenance.